Lilly Announces Agreement to Acquire Dermira
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St futures flat after tech rout; Iran tensions, retail earnings in focus
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Global bond rout pauses as sovereign yields back off multi-decade highs
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Dermira (DERM) Trades Above Deal Price on Speculation of Higher Bid
January 10, 2020 9:45 AM ESTDermira (NASDAQ: DERM) is trading above the Eli Lilly (NYSE: LLY) deal price of $18.75 on speculation of a higher bid. Shares last traded at $19.31. Traders note there was no deal premium, no deal leaks, although shares ramped higher... More
